MOFEBUTAZONE
UNII SPW36WUI5Z

Substance Identification & Data

This profile provides standardized clinical and technical data for Mofebutazone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) SPW36WUI5Z.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2210-63-1 and the RxNorm Concept ID (RxCUI) 30202. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

SPW36WUI5Z

CAS Registry Number

2210-63-1

RxNorm Concept ID

30202

Detailed Substance Profile

Preferred Name

MOFEBUTAZONE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C13H16N2O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

REOJLIXKJWXUGB-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C73089

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

16639

Unique identification number in the NCBI database of chemical substances.

INN ID

1773

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

N1(C(C(CCCC)C(N1)=O)=O)c2ccccc2

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Mofebutazone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.